Adolescent onset RBD converting to PD after 48 years
Objective: To present a patient with adolescent onset dream enactment behaviour who developed PD 48 years later. Background: RBD typically occurs after age 50, and…Rotenone model of Parkinson’s disease: The dosing options in mice revisited
Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
Objective: To investigate the preferences different generational groups (i.e. Traditionalists, Baby Boomers, Generation X-ers, and Millennials) have towards healthcare with regards to time management. Background:…Apolipoprotein E and multiple system atrophy
Objective: This study evaluated genetic associations of Apolipoprotein E alleles with risk of multiple system atrophy (MSA) and α-synuclein pathology, and also examined whether apolipoprotein…[18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment
Objective: We investigated the brain dopaminergic system and glucose metabolism in multiple system atrophy (MSA) patients with cognitive impairment. Background: Since the first report of…Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)
Objective: To evaluate the accuracy of the IPD-MDS-PSP criteria to differentiate PSP-Richardson (PSP-R) from PSP-parkinsonism (PSP-P), the most common PSP phenotypes. Background: The new International…Patient Perspective in Multiple System Atrophy
Objective: To report patient and/ or caregiver perspective in Multiple System Atrophy (MSA). Background: The majority of literature on MSA’s natural history comes from single…Peripheral immune activation was associated with multiple system atrophy
Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study
Objective: To measure the diagnostic properties of clinical indicators of advanced Parkinson Disease (APD). Background: Lack of consensus to define APD may lead to delay…Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?
Objective: To identify if intelligibility or social repercussions of dysarthria determined quality of life in patients with different kinds of movement disorders. Background: Dysarthria in…
- « Previous Page
- 1
- …
- 89
- 90
- 91
- 92
- 93
- …
- 177
- Next Page »